Wilson Sonsini advised EpiBiologics on the deal. EpiBiologics, a biotechnology company building a next-generation antibody-based protein degradation platform for membrane and extracellular drug targets, launched with...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Switch Therapeutics on the transaction and launch. Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised Claritas Capital and Emerald Plus on the deal. Claritas Capital and Emerald Plus announced their investments in Matchday, an interactive entertainment startup focused...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Chroma Medicine on the deal. Genomic medicine company Chroma Medicine announced that it had completed a $135 million Series B financing, which was...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised MacroGenics, Inc. on the deal. The Fourth Circuit affirmed dismissal of a securities class action filed against Wilson Sonsini clients...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Transcarent in the transaction. Transcarent, a health and care experience company that makes it easy for people to access high-quality,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented LENZ in the transaction. Biopharmaceutical company LENZ Therapeutics announced that it raised $83.5 million in an oversubscribed Series B financing....
You must be a Standard 1 Year member to access this content.
Orrick advised Third Rock Ventures on the deal while Wilson Sonsini represented CARGO Therapeutics. Third Rock Ventures announced its investment in the $200 million Series A financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Alteryx on the deal. Alteryx, Inc. announced that it has priced its offering of $450 million aggregate principal amount of its 8.75 percent...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Regie.ai on the Series A transaction. Regie, the generative AI software-as-a-service (SaaS) platform, announced that it has closed its $20.8...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Herzog Fox represented Urgent.ly, while Latham & Watkins and Gross Kleinhendler represented Otonomo. Urgent.ly, Inc. (“Urgently”) and Otonomo Technologies Ltd. announced that they have entered...
You must be a Standard 1 Year member to access this content.
